Metabolic Labeling Reagents for Chondroitin Sulfate

Summary

Dr. Patrick Page-McCaw has developed synthetic analogs of N-acetylgalactosamine, finally enabling researchers to track the biosynthesis of chondroitin sulfate along with other glycans. Stunning images demonstrate incorporation of these metabolic labeling reagents to track neurodevelopmental processes in a zebrafish model system. Notably, the metabolic label can be detected post vivo using a standard "click" chemistry reaction. Further, Dr. Page-McCaw has optimized a background reduction strategy to complement this technology by improving the signal-to-noise ratio.

These reagents are the first to successfully label anabolism of the glycan chondroitin sulfate, a marker that can be used to trace extracellular matrix production, central nervous system injury, and neural development. These reagents would be highly useful in research areas such as brain and spinal cord injury, Alzheimer's disease, and neurogenesis.

Key Advantages

First-to-market metabolic chondroitin sulfate labeling reagents

Compatible with simple detection strategies

Synthesis is easy, efficient, and inexpensive offering an attractive margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventors: 
Patrick Page-McCawGary SulikowskiRobert LinhardtSun Waldron
Licensing manager: 
Mike Villalobos

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter